Patent assignee · US · COMPANY

PROLYNX LLC

17Patents
17Active
17Granted
51Portfolio score

Filing activity: Jun 26, 2009 → Apr 3, 2020 · 3 expiring within 5 years

Most-cited patents

PatentTitleAreaCited byStatus
US8754190B2 Controlled release from macromolecular conjugates Chemistry; Metallurgy 48 Active
US8946405B2 Controlled release from solid supports Human Necessities 35 Active
US8703907B2 Controlled drug release from dendrimers Chemistry; Metallurgy 12 Active
US9387254B2 Prodrugs and drug-macromolecule conjugates having controlled drug release rates Chemistry; Metallurgy 9 Active
US8680315B2 Prodrugs and drug-macromolecule conjugates having controlled drug release rates Chemistry; Metallurgy 4 Active
US10398779B2 Hydrogels with biodegradable crosslinking Emerging Cross-Sectional Technologies 3 Active
US9649385B2 Hydrogels with biodegradable crosslinking Emerging Cross-Sectional Technologies 3 Active
US10967925B2 Mountable cleat apparatus Performing Operations; Transporting 2 Active
US10016411B2 Slow-release conjugates of SN-38 Chemistry; Metallurgy 2 Active
US11179470B2 Hydrogels with biodegradable crosslinking Emerging Cross-Sectional Technologies 1 Active
US11454861B2 Hydrogels with biodegradable crosslinking Emerging Cross-Sectional Technologies 1 Active
US10342792B2 Slow-release conjugates of SN-38 Chemistry; Metallurgy 1 Active
US11181803B2 Hydrogels with biodegradable crosslinking Emerging Cross-Sectional Technologies 1 Active
US10413594B2 Conjugates of somatostatin analogues Human Necessities 0 Active
US11730836B2 Synergistic cancer treatment Performing Operations; Transporting 0 Active
US12364771B2 Conjugation linkers Chemistry; Metallurgy 0 Active
US10086049B2 Conjugates of somatostatin analogues Human Necessities 0 Active

Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.